Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual biological effects of the cytokines interleukin-10 and interferon-γ
Cailin Moira Wilke, Shuang Wei, Lin Wang, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 11, pp. 1529-1541
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
Nature reviews. Cancer (2012) Vol. 12, Iss. 4, pp. 252-264
Open Access | Times Cited: 12348
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll
Current Opinion in Immunology (2012) Vol. 24, Iss. 2, pp. 207-212
Open Access | Times Cited: 1288
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye, Zoaib Rasool
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 616
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li, Ke Wu, Kaixiong Tao, et al.
Hepatology (2012) Vol. 56, Iss. 4, pp. 1342-1351
Open Access | Times Cited: 441
Molecular networks that regulate cancer metastasis
Daniela Spano, Chantal Heck, Pasqualino de Antonellis, et al.
Seminars in Cancer Biology (2012) Vol. 22, Iss. 3, pp. 234-249
Closed Access | Times Cited: 333
Acidity‐Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer
Rundi Song, Tianliang Li, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 31
Closed Access | Times Cited: 235
The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck
Dan P. Zandberg, Scott E. Strome
Oral Oncology (2014) Vol. 50, Iss. 7, pp. 627-632
Closed Access | Times Cited: 224
Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients
Xu‐Chao Zhang, Jun Wang, Guoguang Shao, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 177
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shabnam Shalapour, Michael Karin
Immunity (2019) Vol. 51, Iss. 1, pp. 15-26
Open Access | Times Cited: 173
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions
Valentina Carlini, Douglas M. Noonan, Eslam Abdalalem, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 166
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu, Ruiqi Liu, Bojun Wang, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 1, pp. e001895-e001895
Open Access | Times Cited: 163
Indoleamine 2,3‐dioxygenase: From catalyst to signaling function
Francesca Fallarino, Ursula Grohmann, Paolo Puccetti
European Journal of Immunology (2012) Vol. 42, Iss. 8, pp. 1932-1937
Open Access | Times Cited: 170
Clinicopathologic analysis of programmed cell death-1 and programmed cell death-ligand 1 and 2 expressions in pulmonary adenocarcinoma: comparison with histology and driver oncogenic alteration status
Jaemoon Koh, Heounjeong Go, Bhumsuk Keam, et al.
Modern Pathology (2015) Vol. 28, Iss. 9, pp. 1154-1166
Open Access | Times Cited: 153
Immunotherapy earns its spot in the ranks of cancer therapy
Drew M. Pardoll, Charles G. Drake
The Journal of Experimental Medicine (2012) Vol. 209, Iss. 2, pp. 201-209
Open Access | Times Cited: 135
Targeting Tumors with IL-10 Prevents Dendritic Cell-Mediated CD8+ T Cell Apoptosis
Jian Qiao, Zhida Liu, Chunbo Dong, et al.
Cancer Cell (2019) Vol. 35, Iss. 6, pp. 901-915.e4
Open Access | Times Cited: 129
Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
Omid Hamid, Richard D. Carvajal
Expert Opinion on Biological Therapy (2013) Vol. 13, Iss. 6, pp. 847-861
Closed Access | Times Cited: 117
YY1 regulates cancer cell immune resistance by modulating PD-L1 expression
Emily Hays, Benjamin Bonavida
Drug Resistance Updates (2019) Vol. 43, pp. 10-28
Closed Access | Times Cited: 117
Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
Lin Shui, Xi Yang, Jian Li, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 106
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
Alessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.
OncoImmunology (2015) Vol. 5, Iss. 1, pp. e1064578-e1064578
Open Access | Times Cited: 104
The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104
Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity
Adam J. Lamble, Evan Lind
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 103
Harnessing the Power of the Immune System Via Blockade of PD-1 and PD-L1: A Promising New Anticancer Strategy
Kim A. Reiss, Patrick M. Forde, Julie R. Brahmer
Immunotherapy (2014) Vol. 6, Iss. 4, pp. 459-475
Open Access | Times Cited: 102
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Chiara Porta, Francesca Maria Consonni, Sara Morlacchi, et al.
Cancer Research (2020) Vol. 80, Iss. 13, pp. 2874-2888
Open Access | Times Cited: 98
Anti-inflammatory effect and potential mechanism of betulinic acid on λ-carrageenan-induced paw edema in mice
Zhaoping Ou, Ye Zhao, Lijuan Zhu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109347-109347
Open Access | Times Cited: 96
Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice
Wei Yuan, Xiang‐Ming Lao, Christos Xiao, et al.
Gastroenterology (2019) Vol. 156, Iss. 6, pp. 1890-1904.e16
Closed Access | Times Cited: 94
Page 1 - Next Page

Scroll to top